Hinge Health, Inc.
HNGE
$40.00
-$0.34-0.84%
NYSE
| 03/31/2025 | |||||
|---|---|---|---|---|---|
| Net Income | 164.76% | ||||
| Total Depreciation and Amortization | -18.08% | ||||
| Total Amortization of Deferred Charges | 37.53% | ||||
| Total Other Non-Cash Items | -36.94% | ||||
| Change in Net Operating Assets | -44.85% | ||||
| Cash from Operations | 115.08% | ||||
| Capital Expenditure | 60.77% | ||||
| Sale of Property, Plant, and Equipment | -- | ||||
| Cash Acquisitions | -- | ||||
| Divestitures | -- | ||||
| Other Investing Activities | -205.62% | ||||
| Cash from Investing | -231.43% | ||||
| Total Debt Issued | -- | ||||
| Total Debt Repaid | -- | ||||
| Issuance of Common Stock | 64.41% | ||||
| Repurchase of Common Stock | -- | ||||
| Issuance of Preferred Stock | -- | ||||
| Repurchase of Preferred Stock | -- | ||||
| Total Dividends Paid | -- | ||||
| Other Financing Activities | -- | ||||
| Cash from Financing | 6,855.93% | ||||
| Foreign Exchange rate Adjustments | -- | ||||
| Miscellaneous Cash Flow Adjustments | -- | ||||
| Net Change in Cash | 24.85% | ||||